SCM
Sio Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-36,632
| Closed | -$4.22M | – | 68 |
|
|
2019
Q4 | $4.22M | Sell |
36,632
-86,021
| -70% | -$9.91M | 1% | 25 |
|
|
2019
Q3 | $9.86M | Sell |
122,653
-28,900
| -19% | -$2.32M | 3.18% | 8 |
|
|
2019
Q2 | $11M | Buy |
151,553
+72,400
| +91% | +$5.25M | 2.65% | 8 |
|
|
2019
Q1 | $7.4M | Sell |
79,153
-75,484
| -49% | -$7.05M | 2% | 15 |
|
|
2018
Q4 | $11.3M | Buy |
154,637
+50,461
| +48% | +$3.68M | 4.11% | 3 |
|
|
2018
Q3 | $9.12M | Buy |
104,176
+74,341
| +249% | +$6.51M | 3.13% | 8 |
|
|
2018
Q2 | $2.94M | Buy |
+29,835
| New | +$2.94M | 1.62% | 23 |
|
|
2017
Q4 | – | Sell |
-20,225
| Closed | -$2.38M | – | 36 |
|
|
2017
Q3 | $2.38M | Buy |
+20,225
| New | +$2.38M | 1.23% | 21 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 44 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 39 |
|
|
2016
Q2 | – | Sell |
-153,778
| Closed | -$9.65M | – | 33 |
|
|
2016
Q1 | $9.65M | Buy |
+153,778
| New | +$9.65M | 3.53% | 9 |
|
|
2015
Q4 | – | Sell |
-64,996
| Closed | -$5.22M | – | 42 |
|
|
2015
Q3 | $5.22M | Buy |
64,996
+37,996
| +141% | +$3.05M | 3.58% | 11 |
|
|
2015
Q2 | $3.24M | Buy |
+27,000
| New | +$3.24M | 1.6% | 16 |
|